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Background: In 2010–2011, two large waterborne outbreaks caused by Cryptosporidium hominis affected two cities
in Sweden, Östersund and Skellefteå. We investigated potential post-infection health consequences in people who
had reported symptoms compatible with cryptosporidiosis during the outbreaks using questionnaires.
Methods: We compared cases linked to these outbreaks with non-cases in terms of symptoms present up to eleven
months after the initial infection. We examined if cases were more likely to report a list of symptoms at follow-up than
non-cases, calculating odds ratios (OR) and 95 % confidence intervals (CI) obtained through logistic regression.
Results: A total of 872 (310 cases) and 743 (149 cases) individuals responded to the follow-up questionnaires in
Östersund and Skellefteå respectively. Outbreak cases were more likely to report diarrhea (Östersund OR: 3.3, CI:
2.0-5.3. Skellefteå OR: 3.6, CI: 2.0-6.6), watery diarrhea (Östersund OR: 3.4, CI: 1.9-6.3. Skellefteå OR: 2.8, CI: 1.5-5.1)
abdominal pain (Östersund OR: 2.1, CI: 1.4-3.3, Skellefteå OR: 2.7, CI: 1.5-4.6) and joint pain (Östersund OR: 2.0, CI: 1.2-3.3,
Skellefteå OR: 2.0, CI: 1.1-3.6) at follow-up compared to non-cases.
Conclusions: Our findings suggest that gastrointestinal- and joint symptoms can persist several months after the initial
infection with Cryptosporidium and should be regarded as a potential cause of unexplained symptoms in people who
have suffered from the infection.
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Cryptosporidium is a protozoan parasite that can cause
gastrointestinal illness in humans and animals [1, 2]. Several
species of the parasite have been identified. Cryptosporid-
ium parvum and C. hominis are the most prevalent species
in humans. Cryptosporidiosis is transmitted mainly by the
fecal-oral route, mostly by oocyst-contaminated water or
food, or by direct contact with an infected person or animal
[3].
Cryptosporidiosis occurs worldwide, and in all age groups
[1], although children especially during the first year of life
are frequently and severely affected [2, 4]. Numerous* Correspondence: johan.lindh@icm.uu.se
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the largest occurred in Milwaukee in 1993 where 400 000
people were infected through the public water supply [6].
In Sweden, Cryptosporidium has been a notifiable disease
since 2004. Up to 2009 a mean of 45 (SD: 17) domestically
acquired cases were reported annually [7]. However, the
incidence of cryptosporidiosis is likely to be underes-
timated due to lack of testing [8, 9], especially in an
outbreak situation where only a small proportion of
probable cases are laboratory confirmed [10].
In otherwise healthy individuals infection with Crypto-
sporidium cause gastrointestinal illness. The most fre-
quent symptoms are diarrhea, watery diarrhea, nausea,
vomiting, fever and abdominal pain [1, 11] but infections
may be asymptomatic [3]. Relapse of diarrhea more than
two days after the end of initial diarrheal disease occursicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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gastrointestinal symptoms after initial infection is lim-
ited but persisting diarrhea up to three months after ini-
tial infection has been reported to be more frequent
among cryptosporidiosis cases than controls [13]. Add-
itionally, a recent follow-up study of 53 Cryptosporidium
cases (without control population) indicates persisting
gastrointestinal symptoms in two to eight patients up to
three years after initial infection [14]. Similar to other
gastrointestinal pathogens, Cryptosporidium infection
may also cause reactive arthropathy. Reactive arthropa-
thy after Cryptosporidium infection was first described
in case reports in the 80s [15, 16]. A more recent pro-
spective epidemiological study suggests presence of joint
related symptoms up to three months after the original
infection [13]. In immunocompromised patients the
symptoms may be severe with a prolonged or chronic
infection [1].
In 2010–2011, two large waterborne outbreaks caused
by the same Cryptosporidium genotype (C. hominis
IbA10G2) affected two cities in the Northern part of
Sweden [10]. First in November 2010 in Östersund, a
city of 60,000 people, and two months later in Skellefteå,
a municipality of 72,000 people, situated approximately
450 km northeast of Östersund. Population-based cohort
studies were performed in both cities, and estimated
attack rates of 45 % in Östersund [10] and 28 % in
Skellefteå (manuscript in preparation) were reported.
Identified risk factors for Cryptosporidium infection in
these outbreaks were high consumption of tap water in
Östersund and living in a specific water supply region in
Skellefteå. In order to better understand the conse-
quences of these large outbreaks and to shed further light
on whether Cryptosporidium infection may cause long
term illness in those affected, we performed two sep-
arate follow-up studies using the outbreak cohorts in
Östersund and Skellefteå.Fig. 1 Graphic presentation of the timeline in the Cryptosporidium outbreak anMethods
For this present study, we used data collected in the out-
break cohort studies in order to determine case status
(presence of symptoms during the outbreak, duration of
symptoms), apply exclusion criteria (chronic diseases)
and perform a non-response analysis. Each city’s follow-
up study was analyzed separately. The outbreak and
follow-up timelines is summarized in Fig. 1.
The Östersund study
In mid-January 2011, two months after the onset of the
outbreak, 1,524 people (2.5 %) in a random sample of
persons living in Östersund were invited to take part in
a retrospective cohort study to assess the magnitude of
the outbreak, clinical characteristics and risk factors for
disease [10]. The sample was randomly selected from the
Swedish population registry by statistic Sweden (SCB). A
total of 1,044 responded (69 %) to the outbreak question-
naire of which 481 were men (46 %). On 16 June, 2011,
we invited these 1,044 respondents (henceforth referred
to as the Östersund study) to complete a follow-up ques-
tionnaire regarding post-infection symptoms during the
three months preceding the day of answering the ques-
tionnaire. Responses were recorded until 16 July, 2011,
hence the period of recorded post-infection symptoms in
the Östersund study was 16 March to 16 July, 2011.
Parents or guardians were asked to respond for chil-
dren <15 years of age.
The Skellefteå study
In late May 2011, about five months after the onset of
the outbreak, 1,750 people (2.4 %) in a random sample
of the Skellefteå population were invited to take part in
a retrospective cohort study in order to identify the start,
magnitude and source of the outbreak, and risk factors
for disease (manuscript in preparation). The sample was
randomly selected from the Swedish population registryd follow-up studies in Östersund and Skellefteå, Sweden 2010–2011
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responded (63 %) to the outbreak questionnaire, of
which 532 were men (48 %). On 18 November, 2011, we
invited these 1,099 respondents (henceforth referred to as
the Skellefteå study) to complete a follow-up questionnaire
regarding post-infectious symptoms after 20 August, 2011
until the day of answering the questionnaire. Responses
were recorded until 15 December, 2011, hence the period
of recorded post-infection symptoms in the Skellefteå
study was 20 August to 15 December, 2011. Parents or
guardians were asked to respond for children <15 years
of age.
Case definition
We determined outbreak case status in the Östersund
and Skellefteå studies based on clinical characteristics
reported in the outbreak questionnaire. We defined an
outbreak case of Cryptosporidium infection as a re-
spondent that reported new episodes of diarrhea (more
than three loose stools in one day) and/or watery diar-
rhea and a duration of gastrointestinal symptoms of at
least four days during the outbreak period in each city
(Östersund: 1 November, 2010 to 31 January, 2011, and
Skellefteå: 1 January, 2011 to 31 May, 2011). We defined
respondents not fitting the case definition as non-cases
during the outbreaks.
Data collection
We sent postal questionnaires to the follow-up study
population, accompanied with a letter explaining the
study and a pre-paid envelope for return of the complete
questionnaire to the Public Health Agency of Sweden.
The Skellefteå study population was also given the op-
tion of completing the questionnaire online, accessed
through a link that was sent in the accompanying letter.
The follow-up questionnaire included questions about
symptoms present during the follow-up period (as de-
fined for each study above): loss of appetite, weight loss,
diarrhea, watery diarrhea, bloody diarrhea, abdominal
pain, headache, eye pain, stiff joints, fatigue, joint pain,
swollen joints, joint discomfort, nauseas, vomiting, and a
text area for any other symptoms. All returned paper
questionnaires were optically scanned and transformed
into an electronic database, and merged to the online
questionnaire data (Skellefteå only). Demographic data
were available from the population registry and were
provided when the outbreak cohorts were established.
Exclusion criteria
To avoid potential misclassification of case status,
such as bias at follow-up linked to chronic gastro-
intestinal symptoms present for other reasons than
Cryptosporidium infection, we excluded study partic-
ipants that reported a diagnose of irritable bowelsyndrome or inflammatory bowel disease in the out-
break questionnaire.
Data analysis
We described the characteristics of the study popula-
tions in terms of symptoms present at follow-up, age
and sex by outbreak case status. We examined symp-
toms at follow-up associated to outbreak case status by
calculating odds ratios (OR) and 95 % confidence inter-
vals (CI) obtained through logistic regression [17].
We excluded observations with missing values from
the analysis. We included age and sex in the logistic
regression models in order to adjust the association for
their potential confounding effect. The analysis were
performed in the statistical software R (R core team
2014) version 3.0.3 [18].
Non-response analysis
We examined if sex, age, dwelling-place and case status
of the study population were associated with non-
response by calculating OR and 95 % CI using logistic
regression modeling.
Ethical statement
The study was reviewed and approved by the Stockholm




A total of 872 and 730 individuals responded to the
follow-up questionnaires in the Östersund and Skellefteå
studies respectively (response rates 84 % and 68 %).
In the Skellefteå study, 303 (44 %) responded to the
questionnaire on-line. Before analysis we excluded 60
(41 non-cases and 19 cases) from the Östersund study
and 44 (31 non-cases and 13 cases) from the Skellefteå
study as they met the exclusion criteria. Finally, we in-
cluded 812 individuals in the Östersund study and 686 in
the Skellefteå study in the analysis. The characteristics of
the study populations in each of the studies are presented
in Additional file 1: Table S1. In the Östersund study 310
(38 %) were defined as cases in the outbreak of which
138 (45 %) were men. In the Skellefteå study, 149 (22 %)
were defined as cases in the Skellefteå outbreak of which
73 (49 %) were men. The median age of cases was
32 years (range: 1–93) and 34 years (range: 2–92) in the
Östersund and Skellefteå studies respectively.
Symptoms during the follow-up period
Forty-nine percent of cases in Östersund and fifty-six
percent of cases in Skellefteå reported symptoms at
follow-up, most frequently fatigue, headache, abdominal
pain and diarrhea (Table 1). The median number of
Table 1 Symptoms reported at follow-up among respondents in the Östersund and Skellefteå studies, and its association with case
status, Sweden 2011
Östersund a Skellefteå b
Symptom Cases n (%) Non-cases n (%) ORc (95 % CI) Cases n (%) Non-cases n (%) ORc (95 % CI)
Weight loss 23 (7) 10 (2) 4.0 (1.9–9.0) 6 (4) 13 (2) 1.6 (0.5–4.2)
Watery diarrhea 36 (12) 18 (4) 3.4 (1.9–6.3) 22 (15) 27 (5) 2.8 (1.5–5.1)
Diarrhea 55 (18) 30 (6) 3.3 (2.0–5.3) 26 (17) 26 (5) 3.6 (2.0–6.6)
Abdominal pain 59 (19) 46 (9) 2.1 (1.4–3.3) 28 (19) 38 (7) 2.7 (1.5–4.6)
Rigid joints 37 (12) 38 (8) 2.1 (1.2–3.5) 13 (9) 32 (6) 1.5 (0.7–3.1)
Joint pain 34 (11) 39 (8) 2.0 (1.2–3.3) 21 (14) 44 (8) 2.0 (1.1–3.6)
Loss of appetite 48 (15) 42 (8) 2.0 (1.3–3.1) 18 (12) 37 (7) 1.5 (0.8–2.8)
Fatigue 80 (26) 78 (16) 1.9 (1.3–2.8) 40 (27) 75 (14) 2.0 (1.2–3.2)
Nauseas 44 (14) 40 (8) 1.7 (1.1–2.7) 27 (18) 53 (10) 1.8 (1.1–3.1)
Headache 74 (24) 77 (15) 1.7 (1.2–2.5) 39 (26) 97 (18) 1.4 (0.9–2.3)
Joint discomfort 28 (9) 35 (7) 1.7 (1.0–2.9) - - -
Ocular pain 31 (10) 35 (7) 1.6 (1.0–2.7) 17 (11) 36 (7) 1.7 (0.9–3.1)
Swollen joints 12 (4) 18 (4) 1.5 (0.7–3.3) 7 (5) 21 (4) 1.2 (0.4–2.9)
Vomiting 20 (6) 34 (7) 0.9 (0.5–1.5) 10 (4) 25 (5) 1.1 (0.5–2.3)
Bloody diarrhea 2 (1) 2 (0) 3 (2) 0 (0) -
a 310 cases and 502 non-cases
b 149 cases and 537 non-cases
c Adjusted for age and sex
Bold indicates significant at 0.05 level
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at follow-up was three in both Östersund (range: 1–10)
and Skellefteå (range: 1–14).
The results from the logistic regression models are
presented in Table 1 and visualized in Additional file 2:
Figure S1a and Additional file 3: Figure S1b. In both
studies, outbreak cases were more likely to report diar-
rhea (Östersund OR: 3.3, 95 % CI: 2.0-5.3. Skellefteå OR:
3.6, 95 % CI: 2.0-6.6), watery diarrhea (Östersund OR:
3.4, 95 % CI: 1.9-6.3. Skellefteå OR: 2.8 95 % CI: 1.5-5.1)
and abdominal pain (Östersund OR: 2.1, 95 % CI: 1.4-
3.3, Skellefteå OR: 2.7, 95 % CI: 1.5-4.6) at follow-up
compared to non-cases. Fatigue, nausea and joint pain
was weakly, yet significantly, associated to being a case
in the outbreak in both studies (Table 1). Further, weight
loss, loss of appetite, stiff joints and headache was sig-
nificantly associated with being a case in the outbreak in
Östersund, but not in Skellefteå (Table 1).
Non-response analysis
In both the Östersund and Skellefteå studies, the older
age groups were more likely to respond to the follow-up
questionnaire compared to the reference age group
0–5 years (Östersund 41–65 years OR: 1.7, 95 % CI:
1.1-2.5. Östersund >65 years OR: 3.4, 95 % CI: 1.9-
6.2. Skellefteå >65 years OR: 3.4, 95 % CI: 2.2-6.4).
Sex, dwelling-place and case status did not explain non-
response in any of the studies.Discussion
We investigated post-infection health consequences fol-
lowing two separate waterborne C. hominis outbreaks in
Northern Sweden based on data from a random sample
of the population. The overall findings between the two
studies are comparable and suggest that outbreak cases
in both Östersund and Skellefteå were more likely to
have gastrointestinal- and joint-related symptoms.
Case-based analysis of the time between initial infec-
tion and post-infection symptoms could not be per-
formed in our studies because the individual time of
completing the follow-up questionnaire was not docu-
mented. On study population level the time between ini-
tial infection and point of follow-up could vary between
2.5-8.5 months in Östersund, and 2.5-11.5 months in
Skellefteå. Our findings suggest that the health conse-
quences may persist even longer than stated in previous
reports [13, 15] although persisting gastrointestinal
symptoms between 24 and 36 months after infection
have been described in up to eight of 53 Cryptosporid-
ium cases [14]. Early childhood Cryptosporidium infec-
tion and diarrhea has been linked to impaired physical
fitness 4–7 years later [19]. However this evidence
comes from investigations in a low-income setting. Fur-
thermore, similar long-term effects following initial in-
fection have been recorded for other gastrointestinal
parasites. For example giardiasis have been documented
to cause long term gastrointestinal symptoms [20, 21]
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during a large waterborne outbreak in Norway.
The full consequences of the outbreaks that occurred
in Östersund and Skellefteå cannot be evaluated through
these studies. For example, we did not evaluate the
severity and effect on sick leave among our study popu-
lation. However the prevalence of health problems
several months after the outbreaks suggests that total
cryptosporidiosis-related cost of illness may be higher
than what could be expected from only the infection.
Our results may be influenced by recall bias and non-
response bias. Recall bias may affect cases and non-cases
differently since cases may have been more self-
observant due to the initial infection and therefore more
prone to remember more symptoms. A proportion of
the invited study population was lost to follow-up (16 %
and 32 %). Non-response analysis did not suggest that
cases were more likely to respond. Our findings derive
from two waterborne outbreaks in Sweden with almost
50000 people estimated to be infected. Only a small pro-
portion of the cases were tested and laboratory confirmed
and no additional sampling was performed among our
study population. The lack of laboratory confirmation is a
limitation in our study and leads to four minor concerns
regarding misclassification of case status:
First, during the outbreak periods, norovirus was
circulating in Sweden and it is likely that some of our
cases actually suffered from norovirus infection (or other
gastrointestinal pathogens) rather than cryptosporidiosis.
However, our case definition required a duration of
symptoms of more than four days, which is longer than
what is normally expected from norovirus infections
[23], thus likely excluding potential norovirus cases.
Additionally, Cryptosporidium was detected in the drink-
ing water during the outbreak period in Östersund, sug-
gesting that cases of gastroenteritis during this time
were likely to be explained by Cryptosporidium infection
[10]. The 149 laboratory confirmed cases of cryptospor-
idiosis related to the outbreak in Östersund were all
negative for other gastrointestinal pathogens, including
norovirus. During the peak in the Skellefteå outbreak
(15–26 April, 2011), 45/74 laboratory confirmed Crypto-
sporidium cases were also analyzed for norovirus and
one was positive. It is also likely that the frequency of
misclassification of cases differs between the two studies
due to the difference in duration of the outbreaks. The
outbreak period in Skellefteå was estimated to have
lasted for five months, a rather long time period when
other pathogens could have caused similar symptoms in
line with our case definition. In Östersund on the other
hand, the outbreak was recognized and controlled within
a month after it started [10], decreasing the time of risk
for misclassification of case status. This may explain why
a number of symptoms (weight loss, loss of appetite, stiffjoints and headache) were associated with outbreak case
status only in the Östersund study and why measures of
association were often stronger in the Östersund study
than in the Skellefteå study [10]. Furthermore, Crypto-
sporidium oocysts were identified in drinking water from
Östersund [10] while no oocysts could be found in
drinking water from Skellefteå (unpublished data). This
suggests that the cases in Östersund consumed more oo-
cysts then the cases in Skellefteå and therefor were more
frequently and severally effected by infections and se-
quelae. However, these points remain speculative.
Second, persons who constantly suffer from intermit-
tent diarrhea are likely to have been classified as cases in
the outbreak and are also likely to report similar symp-
toms at follow-up. We made an attempt to minimize
this effect by excluding cases with diagnosed irritable
bowel syndrome or inflammatory bowel disease. Thus
persons that have undiagnosed persisting gastrointestinal
symptoms and reported them as new episodes of diar-
rhea may still be included in our studies and defined as
outbreak cases as well as cases with symptoms at follow-
up, resulting in an overestimation of the associations.
Third, if asymptomatic and mild cases suffered from
Cryptosporidium related post-infection symptoms they
are likely to contribute to the prevalence of symptoms
in the non-case group at follow-up, thus diluting the
true association, suggesting that our findings are
underestimated.
Finally, we lack information about travel history during
the outbreak- and follow-up periods, preventing exclu-
sion of travel-related infections in our studies. The
possible misclassification of outbreak cases due to non-
cryptosporidiosis travel-related infections during the
outbreak period may further dilute our results. Travel-
related infections during the follow-up period are how-
ever a smaller problem since the travel related symptoms
are likely to be evenly distributed among outbreak cases
and non-cases.
Conclusion
The data from these two studies conducted after two
major Cryptosporidium outbreaks provide unique possi-
bilities to describe post-infection health consequences.
Our findings support previous reports that persisting
gastrointestinal symptoms can continue several months
after the initial infection with Cryptosporidium, suggest-
ing that the public health consequences of the outbreaks
that occurred in Northern Sweden go beyond the out-
break period and that the consequences of Crypto-
sporidium infections are underestimated worldwide.
Implications
A history of cryptosporidiosis should be regarded as a
potential cause in patients with long lasting gastrointestinal
Rehn et al. BMC Public Health  (2015) 15:529 Page 6 of 6symptoms. Furthermore, our findings suggest that long-
term symptoms need to be included in calculations on the
total health and economic burden of cryptosporidiosis.
Lastly, in order to find out how long-term symptoms may
persist after infection, even longer follow-up periods of
Cryptosporidium cases are needed.
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